Revenue (Quarterly) Chart

View Revenue (Quarterly) for AJOY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.0288M
September 30, 2022 0.07M
June 30, 2022 0.0676M
March 31, 2022 0.0228M
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018 10.21M
June 30, 2018 9.528M
March 31, 2018 10.21M
December 31, 2017 16.36M
September 30, 2017 19.86M
June 30, 2017 12.05M
Date Value
March 31, 2017 10.67M
December 31, 2016 15.79M
September 30, 2016 17.36M
June 30, 2016 16.43M
March 31, 2016 15.16M
December 31, 2015 21.65M
September 30, 2015 22.67M
June 30, 2015 15.68M
March 31, 2015 16.00M
December 31, 2014 19.01M
September 30, 2014 20.18M
June 30, 2014 13.99M
March 31, 2014 14.47M
December 31, 2013 17.96M
September 30, 2013 18.75M
June 30, 2013 12.89M
March 31, 2013 13.38M
December 31, 2012 14.81M
September 30, 2012 15.36M
June 30, 2012 10.01M
March 31, 2012 10.38M
December 31, 2011 11.97M
September 30, 2011 12.21M
June 30, 2011 7.212M
March 31, 2011 7.428M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
CS Diagnostics Corp. 0.1098M
Aibotics, Inc. 0.00
GeneDx Holdings Corp. 114.44M
Tenax Therapeutics, Inc. 0.00
NRC Health 35.39M